IDEAS home Printed from https://ideas.repec.org/f/pri238.html
   My authors  Follow this author

David Blaine Ridley

Personal Details

First Name:David
Middle Name:Blaine
Last Name:Ridley
Suffix:
RePEc Short-ID:pri238
[This author has chosen not to make the email address public]
http://faculty.fuqua.duke.edu/~dbr1/

Affiliation

(in no particular order)

Fuqua School of Business
Duke University

Durham, North Carolina (United States)
http://www.fuqua.duke.edu/

(919) 660-7700
(919) 684-2818
Box 90120, Durham, NC 27708-0120
RePEc:edi:fsdukus (more details at EDIRC)

Department of Economics
Duke University

Durham, North Carolina (United States)
http://www.econ.duke.edu/

(919) 660-1800
(919) 684-8974
305 Social Sciences Building, Box 90097, Durham, NC 27708-0097
RePEc:edi:dedukus (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
  2. Ali Yurukoglu & Eli Liebman & David B. Ridley, 2012. "The Role of Government Reimbursement in Drug Shortages," NBER Working Papers 17987, National Bureau of Economic Research, Inc.
  3. David B. Ridley, 2009. "Herding versus Hotelling: Market Entry with Costly Information," Levine's Working Paper Archive 814577000000000174, David K. Levine.

Articles

  1. Ali Yurukoglu & Eli Liebman & David B. Ridley, 2017. "The Role of Government Reimbursement in Drug Shortages," American Economic Journal: Economic Policy, American Economic Association, vol. 9(2), pages 348-382, May.
  2. Ridley, David B. & Zhang, Su, 2017. "Regulation of price increases," International Journal of Industrial Organization, Elsevier, vol. 50(C), pages 186-213.
  3. David B. Ridley, 2015. "Payments, Promotion, And The Purple Pill," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 86-103, January.
  4. Joshua S. Gans & David B. Ridley, 2013. "Innovation Incentives under Transferable Fast-Track Regulatory Review," Journal of Industrial Economics, Wiley Blackwell, vol. 61(3), pages 789-816, September.
  5. Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013. "Pharmaceutical followers," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 538-553.
  6. Picone, Gabriel A. & Ridley, David B. & Zandbergen, Paul A., 2009. "Distance decreases with differentiation: Strategic agglomeration by retailers," International Journal of Industrial Organization, Elsevier, vol. 27(3), pages 463-473, May.
  7. David B. Ridley, 2008. "Herding versus Hotelling: Market Entry with Costly Information," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 17(3), pages 607-631, September.
  8. Henry G. Grabowski & David B. Ridley & Kevin A. Schulman, 2007. "Entry and competition in generic biologics," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 439-451.
  9. David Ridley & Kirsten Axelsen, 2006. "Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence," PharmacoEconomics, Springer, vol. 24(3), pages 65-78, December.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.

    Cited by:

    1. Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
    2. Alderighi, Marco & Bianchi, Carluccio & Lorenzini, Eleonora, 2016. "The impact of local food specialities on the decision to (re)visit a tourist destination: Market-expanding or business-stealing?," Tourism Management, Elsevier, vol. 57(C), pages 323-333.
    3. Chatterjee, Chirantan & Kubo, Kensuke & Pingali, Viswanath, 2015. "The consumer welfare implications of governmental policies and firm strategy in markets for medicines," Journal of Health Economics, Elsevier, vol. 44(C), pages 255-273.

  2. Ali Yurukoglu & Eli Liebman & David B. Ridley, 2012. "The Role of Government Reimbursement in Drug Shortages," NBER Working Papers 17987, National Bureau of Economic Research, Inc.

    Cited by:

    1. Alpert, Abby & Duggan, Mark & Hellerstein, Judith K., 2013. "Perverse reverse price competition: Average wholesale prices and Medicaid pharmaceutical spending," Journal of Public Economics, Elsevier, vol. 108(C), pages 44-62.
    2. Ernst R. Berndt & Rena M. Conti & Stephen J. Murphy, 2017. "The Landscape of US Generic Prescription Drug Markets, 2004-2016," NBER Working Papers 23640, National Bureau of Economic Research, Inc.
    3. Jeffrey Clemens & Joshua D. Gottlieb, 2013. "In the Shadow of a Giant: Medicare's Influence on Private Physician Payments," NBER Working Papers 19503, National Bureau of Economic Research, Inc.
    4. Jeffrey Clemens & Joshua D. Gottlieb, 2012. "Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?," Discussion Papers 11-017, Stanford Institute for Economic Policy Research.
    5. Casey B. Mulligan & Kevin K. Tsui, 2016. "The Upside-down Economics of Regulated and Otherwise Rigid Prices," NBER Working Papers 22305, National Bureau of Economic Research, Inc.

  3. David B. Ridley, 2009. "Herding versus Hotelling: Market Entry with Costly Information," Levine's Working Paper Archive 814577000000000174, David K. Levine.

    Cited by:

    1. Espínola-Arredondo, Ana & Muñoz-García, Félix, 2013. "When does environmental regulation facilitate entry-deterring practices," Journal of Environmental Economics and Management, Elsevier, vol. 65(1), pages 133-152.
    2. Ana Espínola-Arredondo & Félix Muñoz-García, 2016. "Profit-enhancing environmental policy: uninformed regulation in an entry-deterrence model," Journal of Regulatory Economics, Springer, vol. 50(2), pages 146-163, October.
    3. Conze, Maximilian & Kramm, Michael, 2013. "The Recommendation Effect in the Hotelling Game - A New Result for an Old Model," Ruhr Economic Papers 460, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    4. Espínola-Arredondo, Ana & Gal-Or, Esther & Muñoz-García, Félix, 2011. "When should a firm expand its business?," International Journal of Industrial Organization, Elsevier, vol. 29(6), pages 729-745.
    5. Ana Espinola-Arredondo & Felix Munoz-Garcia, 2011. "Environmental Protection Agencies: Measuring the Welfare Benefits from Regulation under Different Information Contexts," Working Papers 2011-11, School of Economic Sciences, Washington State University.
    6. Aurélie Bonein & Stéphane Turolla, 2017. "Spatial competition with demand uncertainty: A laboratory experiment," Working Papers SMART - LERECO 17-12, INRA UMR SMART-LERECO.
    7. Bonein, Aurélie & Turolla, Stéphane, 2009. "Sequential location under one-sided demand uncertainty," Research in Economics, Elsevier, vol. 63(3), pages 145-159, September.
    8. Munoz-Garcia Felix, 2012. "A systematic procedure for finding Perfect Bayesian Equilibria in Incomplete Information Games," Journal of Industrial Organization Education, De Gruyter, vol. 6(1), pages 1-18, December.
    9. Mark Armstrong & Steffen Huck, 2011. "Behavioral Economics as Applied to Firms: A Primer," Antitrust Chronicle, Competition Policy International, vol. 1.
    10. Muñoz-Garcia Félix & Espinola-Arredondo Ana, 2015. "The Signaling Role of Subsidies," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 15(1), pages 1-22, January.
    11. Ridley, David B. & Zhang, Su, 2017. "Regulation of price increases," International Journal of Industrial Organization, Elsevier, vol. 50(C), pages 186-213.
    12. Felix Munoz-Garcia & Gulnara Zaynutdinova, 2013. "Capacity Constrained Firms and Expansion Subsidies: Should Governments Avoid Generous Subsidies?," Journal of Industry, Competition and Trade, Springer, vol. 13(4), pages 563-597, December.
    13. Ana Espinola-Arredondo & Esther Gal-Or & Felix Munoz-Garcia, 2009. "When Should a Firm Expand Its Business? The Signaling Implications of Business Expansion," Working Papers 2008-16, School of Economic Sciences, Washington State University.
    14. Ana Espinola-Arredondo & Felix Munoz-Garcia, 2013. "Can Poorly Informed Regulators Hinder Competition?," Working Papers 2013-3, School of Economic Sciences, Washington State University.
    15. Ana Espinola-Arredondo & Felix Munoz-Garcia & Jude Bayham, 2011. "Promoting Lies through Regulation: Deterrence Impacts of Flexible versus Inflexible Policy," Working Papers 2011-3, School of Economic Sciences, Washington State University.
    16. Picone, Gabriel A. & Ridley, David B. & Zandbergen, Paul A., 2009. "Distance decreases with differentiation: Strategic agglomeration by retailers," International Journal of Industrial Organization, Elsevier, vol. 27(3), pages 463-473, May.
    17. Kultti Klaus, 2011. "Sellers Like Clusters," The B.E. Journal of Theoretical Economics, De Gruyter, vol. 11(1), pages 1-28, December.
    18. Andrey Zaikin & Ana Espinola-Arredondo, 2012. "The Carrot or the Stick: Water Allocation Strategies for Uzbekistan," Working Papers 2012-2, School of Economic Sciences, Washington State University.
    19. Ana Espinola-Arredondo & Felix Munoz-Garcia, 2011. "The Informative Role of Subsidies," Working Papers 2011-10, School of Economic Sciences, Washington State University.

Articles

  1. Ali Yurukoglu & Eli Liebman & David B. Ridley, 2017. "The Role of Government Reimbursement in Drug Shortages," American Economic Journal: Economic Policy, American Economic Association, vol. 9(2), pages 348-382, May.
    See citations under working paper version above.
  2. David B. Ridley, 2015. "Payments, Promotion, And The Purple Pill," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 86-103, January.

    Cited by:

    1. Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
    2. Fern Terris-Prestholt & Frank Windmeijer, 2015. "How To Sell A Condom? The Impact Of Demand Creation Tools On Male And Female Condom Sales In Resource Limited Settings," Working Papers 150017, Canadian Centre for Health Economics.
    3. Su Liu & Deborah Chollet, "undated". "Price and Income Elasticity of the Demand for Health Insurance and Health Care Services: A Critical Review of the Literature," Mathematica Policy Research Reports dbf03ba11863430593b0b825f, Mathematica Policy Research.
    4. Avi Dor & William Encinosa, 2004. "How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs," NBER Working Papers 10738, National Bureau of Economic Research, Inc.
    5. Eisenberg, Matthew D. & Avery, Rosemary J. & Cantor, Jonathan H., 2017. "Vitamin panacea: Is advertising fueling demand for products with uncertain scientific benefit?," Journal of Health Economics, Elsevier, vol. 55(C), pages 30-44.

  3. Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013. "Pharmaceutical followers," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 538-553.
    See citations under working paper version above.
  4. Picone, Gabriel A. & Ridley, David B. & Zandbergen, Paul A., 2009. "Distance decreases with differentiation: Strategic agglomeration by retailers," International Journal of Industrial Organization, Elsevier, vol. 27(3), pages 463-473, May.

    Cited by:

    1. Pim Heijnen & Marco A. Haan & Adriaan R. Soetevent, 2012. "Screening for Collusion: A Spatial Statistics Approach," Tinbergen Institute Discussion Papers 12-058/1, Tinbergen Institute.
    2. Reigadinha, Tânia & Godinho, Pedro & Dias, Joana, 2017. "Portuguese food retailers – Exploring three classic theories of retail location," Journal of Retailing and Consumer Services, Elsevier, vol. 34(C), pages 102-116.
    3. Isabelle M. Nilsson & Oleg A. Smirnov, 2017. "Clustering vs. relative location: Measuring spatial interaction between retail outlets," Papers in Regional Science, Wiley Blackwell, vol. 96(4), pages 721-741, November.
    4. Schuetz, Jenny, 2014. "Do art galleries stimulate redevelopment?," Journal of Urban Economics, Elsevier, vol. 83(C), pages 59-72.
    5. Jenny Schuettz, 2013. "Do Art Galleries Stimulate Redevelopment?," Working Paper 9121, USC Lusk Center for Real Estate.
    6. Kuangnen Cheng & Hui-Ping Chen & Jason Lee, 2015. "Competition behavior in service frequency for U.S. airlines," Service Business, Springer;Pan-Pacific Business Association, vol. 9(1), pages 1-16, March.
    7. Hsu, Wen-Tai & Lu, Yi & Ng, Travis, 2014. "Does competition lead to customization?," Journal of Economic Behavior & Organization, Elsevier, vol. 106(C), pages 10-28.
    8. Buechel, Berno & Klein, Jan, 2014. "Do Consumers' Preferences Really Matter? - A Note on Spatial Competition with Restricted Strategies," MPRA Paper 55288, University Library of Munich, Germany.
    9. Pim Heijnen & Adriaan Soetevent, 2014. "Price Competition on Graphs," Tinbergen Institute Discussion Papers 14-131/VII, Tinbergen Institute.
    10. Aurélie Bonein & Stéphane Turolla, 2017. "Spatial competition with demand uncertainty: A laboratory experiment," Working Papers SMART - LERECO 17-12, INRA UMR SMART-LERECO.
    11. Schuetz, Jenny, 2014. "Why Are Wal-Mart and Target Next-Door Neighbors?," Finance and Economics Discussion Series 2014-81, Board of Governors of the Federal Reserve System (U.S.).
    12. Wieland, Thomas, 2014. "Räumliches Einkaufsverhalten und Standortpolitik im Einzelhandel unter Berücksichtigung von Agglomerationseffekten: Theoretische Erklärungsansätze, modellanalytische Zugänge und eine empirisch-ökonome," MPRA Paper 77163, University Library of Munich, Germany.
    13. Lijesen, M.G., 2010. "Empirical applications of spatial competition; an interpretative literature review," Serie Research Memoranda 0006, VU University Amsterdam, Faculty of Economics, Business Administration and Econometrics.
    14. Jenny Schuetz & Richard K. Green, 2013. "Is the Art Market More Bourgeois Than Bohemian?," Working Paper 18, USC Lusk Center for Real Estate.
    15. Marcon, Eric & Traissac, Stéphane & Puech, Florence & Lang, Gabriel, 2015. "Tools to Characterize Point Patterns: dbmss for R," Journal of Statistical Software, Foundation for Open Access Statistics, vol. 67(c03).
    16. Yi Deng & Gabriel Picone, 2013. "Strategic Clustering and Competition by Alcohol Retailers: An Emperical Anlysis of Entry and Location Decisions," Working Papers 1013, University of South Florida, Department of Economics.

  5. David B. Ridley, 2008. "Herding versus Hotelling: Market Entry with Costly Information," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 17(3), pages 607-631, September.
    See citations under working paper version above.
  6. Henry G. Grabowski & David B. Ridley & Kevin A. Schulman, 2007. "Entry and competition in generic biologics," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 439-451.

    Cited by:

    1. María-Isabel Farfan-Portet & Sophie Gerkens & Isabelle Lepage-Nefkens & Irmgard Vinck & Frank Hulstaert, 2014. "Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(3), pages 223-228, April.
    2. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680, April.
    3. Mark Trusheim & Murray L. Aitken & Ernst R. Berndt, 2010. "Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?," NBER Working Papers 16014, National Bureau of Economic Research, Inc.
    4. François Bocquet & Anaïs Loubière & Isabelle Fusier & Anne-Laure Cordonnier & Pascal Paubel, 2016. "Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience," PharmacoEconomics, Springer, vol. 34(11), pages 1173-1186, November.
    5. Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
    6. Jorge Mestre-Ferrandiz & Adrian Towse & Mikel Berdud, 2016. "Biosimilars: How Can Payers Get Long-Term Savings?," PharmacoEconomics, Springer, vol. 34(6), pages 609-616, June.
    7. Trusheim Mark R. & Aitken Murray L. & Berndt Ernst R., 2010. "Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?," Forum for Health Economics & Policy, De Gruyter, vol. 13(1), pages 1-45, July.
    8. François Bocquet & Pascal Paubel & Isabelle Fusier & Anne-Laure Cordonnier & Claude Pen & Martine Sinègre, 2014. "Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 315-326, June.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 3 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-COM: Industrial Competition (2) 2009-03-14 2013-10-18
  2. NEP-HEA: Health Economics (2) 2012-04-23 2013-10-18
  3. NEP-CTA: Contract Theory & Applications (1) 2009-03-14
  4. NEP-ENT: Entrepreneurship (1) 2009-03-14
  5. NEP-IPR: Intellectual Property Rights (1) 2013-10-18
  6. NEP-MIC: Microeconomics (1) 2009-03-14
  7. NEP-MKT: Marketing (1) 2013-10-18

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, David Blaine Ridley should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.